给大脑中动脉闭塞24h模型大鼠缺血边缘区注射粒细胞-巨噬细胞集落刺激因子基因转染的骨髓基质干细胞。结果显示,相比于单纯骨髓基质干细胞移植,接受粒细胞-巨噬细胞集落刺激因子基因转染骨髓基质干细胞移植的脑缺血大鼠,脑梗死体积减少,细胞凋亡数量减少,血管生成因子表达增加,缺血边缘带血管密度增加,神经功能增强
Granulocyte-macrophage colony-stimulating
factor-transfected bone marrow stromal cells for the treatment of ischemic stroke**☆
Xingjian Lin1, Yingdong Zhang1, 2, Weiguo Liu1, Jingde Dong1, Jie Lu1, Qing Di1, Jingping Shi1
1Nanjing Medical University, Affiliated Nanjing Brain Hospital, Department of Neurology, Nanjing 210029, Jiangsu Province, China 2Nanjing Medical University, Affiliated Nanjing First Hospital, Department of Neurology, Nanjing 210029, Jiangsu Province, China
NEURAL REGENERATION RESEARCH Volume 7, Issue 16, June 2012
Cite this article as: Neural Regen Res. 2012;7(16):1220-1227.

doc.guandang.net
Abstract
Adult, male, Sprague-Dawley rats were injected with granulocyte-macrophage colony-stimulating factor-transfected bone marrow stromal cells (GM-CSF-BMSCs) into the ischemic boundary zone at 24 hours after onset of middle cerebral artery occlusion. Results showed reduced infarct volume, decreased number of apoptotic cells, improved neurological functions, increased angiogenic factor expression, and increased vascular density in the ischemic boundary zone in rats that underwent GM-CSF-BMSCs transplantation compared with the BMSCs group. Experimental findings
suggested that GM-CSF-BMSCs could serve as a potential therapeutic strategy for ischemic stroke and are superior to BMSCs alone.
Xingjian Lin☆, M.D.,
Associate chief physician, Nanjing Medical University, Affiliated Nanjing Brain Hospital, Department of Neurology, Nanjing 210029, Jiangsu Province, China
Xingjian Lin and Weiguo Liu contributed equally to this paper.
Corresponding author:
Yingdong Zhang, M.D., Chief physician, Nanjing Medical University, Affiliated Nanjing Brain Hospital, Department of Neurology, Nanjing 210029, Jiangsu Province, China; Nanjing Medical University, Affiliated Nanjing First Hospital, Department of Neurology, Nanjing 210029, Jiangsu Province, China zhangyingdong2006@ yahoo.com.cn
Received: 2012-01-29 Accepted: 2012-04-27 (N20111123001/YJ)
Lin XJ, Zhang YD, Liu WG, Dong JD, Lu J, Di Q, Shi JP. Granulocyte-macrophage colony-stimulating
factor-transfected bone marrow stromal cells for the treatment of ischemic stroke. Neural Regen Res. 2012;7(16):1220-1227.
doc.guandang.net
doc.guandang.net
doi:10.3969/j.issn.1673-5374.2012.16.003
Key Words
bone marrow stromal cells; granulocyte-macrophage colony-stimulating factor; gene transfection; ischemic stroke; transplantation; stem cells; neural regeneration
Abbreviations
GM-CSF, granulocyte-macrophage colony-stimulating factor; BMSCs, bone marrow stromal cells; MCAO, middle cerebral artery occlusion; mNSS, modified neurological severity scores
cell proliferation[10-11]. The mechanisms of functional recovery following BMSC
transplantation are more likely due to the release of trophic factors that promote
neural differentiation of BMSCs and cellular integration within injured ischemic sites[10-11]. Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a well-known
hematopoietic cytokine and was originally identified because of its ability to stimulate hematopoietic cell differentiation and function[12]. More recently, GM-CSF has attracted attention, because of its effects on neural cell proliferation and differentiation. Previous studies have shown that
exogenous GM-CSF stimulates neuronal progenitor proliferation, prevents neuronal apoptosis, improves functional recovery following experimental spinal cord contusion
INTRODUCTION
Bone marrow stromal cells (BMSCs) exhibit characteristics of multipotential stem cells. BMSCs can be expanded in vitro and induced to differentiate into osteogenic, chondrogenic, adipogenic, and other
mesenchymal lineages[1], such as neuronal cells[2-3]. Recent studies have shown that BMSC transplantation results in therapeutic benefits following traumatic brain injury,
ischemic brain injury, or spinal cord injury[4-8]. However, post-injury transplantations
resulted in central nervous system protein expression in < 20% of transplanted cells[9]. BMSCs provide a stromal microenvironment for hematopoiesis and produce an array of trophic factors and cytokines that influence
1220
重组人粒细胞-巨噬细胞集落刺激因子的研究进展综述...GM—CSF主要用于治疗放、化疗及骨髓移植后的白 细胞...肥大细胞、内皮细胞、成纤维细胞、骨髓基质细胞、某 ...
重组人粒细胞-巨噬细胞集落刺激因子新用途_医药...地用于治疗恶性肿瘤放、 减少症, 以及骨髓移植、 ...因此, 推测 45/0$123 促进缺血组织血管新生的作 ...
人sFlt-1基因转染骨髓基质细胞对K562细胞生长的影响_专业资料。目的:通过转基因的方法获得人可溶性血管内皮生长因子受体1(sFh-1)蛋白的稳定表达,并检测其对K562...
重组反转录病毒碱性成纤维细胞生长因子基因转染对人骨髓基质细胞成骨的影响_专业资料。背景:国内外有关成纤维细胞生长因子基因转染促血管和促肌肉生长的研究较多,...
因子基因转染骨髓间充质干细胞移植治疗疾病研究进展_...④ 可分泌多种细胞冈子、集落刺激因子、干细胞生长...一2等抑制脑细胞凋 亡,减轻神经组织的进一步缺血...
B7-1与GM-CSF双顺反子慢病毒转染骨髓基质细胞的研究 目的研究B7-1和粒-巨噬细胞集落刺激因子(GM-CSF)双基因共表达慢病毒载体是否可介导目的基因在人骨髓...
重组人粒细胞 - 巨噬细胞集落刺激因子菌种稳定性研究李 1 , 徐维明2 , 杨...因而 ,它在加速骨髓移植病人的造血恢复 、 增强癌症病人对化疗的耐受性 ,治疗...
( 12) 骨髓干细胞移植治疗脑梗死的进展刘红娟摘要 ...BMSCs 还易于外源基因的转染和表达, 的载体将外源...Sprigg et al 用粒细胞集落 刺激因子 动员 36 例...
替代了骨髓干细胞 移植.使得自体和异体PBSCs移植都...(G.CSF)或粒细胞.巨噬细胞 集落刺激因子(GM-CSF...干细胞联合移植以及用基因重组人G-CSF转染的骨髓干...
重组人粒2巨噬细胞集落刺 激因子 ( rh GM2CSF ) 、 重组人白细胞介素23 (...脐带血中长期培养启动细胞在转染 FL 和∏ TPO 基因 或 3 骨髓基质细胞层上的...
热门文档